Formulation of human antibodies for treating TNF-alpha associated disorders

摘要

A liquid aqueous pharmaceutical formulation with a pH between 4-8 which contains a high protein concentration, including an antibody concentration ranging from 20-130mg/ml and has a shelf life of at least 18 months. The formulation can be used in the manufacture of a medicament to treat a disorder in which TNF alpha activity is detrimental.